08-2029
|
Phenotype-based Screens to Identify Genetic Factors Asso
Phenotype-based Screens to Identify Genetic Factors Asso
|
03-2029
|
Genomic surveillance for artemisinin resistance in Afric
Genomic surveillance for artemisinin resistance in Afric
|
10-2028
|
A Multicenter, Adaptive, Randomized, Blinded Controlled
A Multicenter, Adaptive, Randomized, Blinded Controlled
|
10-2028
|
A Phase I/III Randomized, Double-blind Study to Evaluate
A Phase I/III Randomized, Double-blind Study to Evaluate
|
02-2028
|
A Multicenter, Adaptive, Randomized, Controlled Trial Pl
A Multicenter, Adaptive, Randomized, Controlled Trial Pl
|
09-2027
|
Reparixin 1200 mg three times a day as add-on therapy t
Reparixin 1200 mg three times a day as add-on therapy t
|
03-2027
|
Mechanisms, Markers, and Risk Factors in Friedreich's At
Mechanisms, Markers, and Risk Factors in Friedreich's At
|
11-2026
|
ARLG Pneumonia Direct Pilot Synopsis
ARLG Pneumonia Direct Pilot Synopsis
|
10-2026
|
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED
|
10-2026
|
Protocol: C4671002
Protocol: C4671002
|
10-2026
|
Protocol: C4671006
Protocol: C4671006
|
09-2026
|
Protocol: C4671005
Protocol: C4671005
|
06-2026
|
Chemogenomic Profiling of Plasmodium Falciparum Response
Chemogenomic Profiling of Plasmodium Falciparum Response
|
06-2026
|
Protocol: INSIGHT 016
Protocol: INSIGHT 016
|
06-2026
|
Evaluation of the Feasibility and Reproducibility of 2
Evaluation of the Feasibility and Reproducibility of 2
|
03-2026
|
A Phase 2b, Multicenter, Randomized, Open-Label, Assesso
A Phase 2b, Multicenter, Randomized, Open-Label, Assesso
|
01-2026
|
Accelerating discovery of an efficacious Plasmodium viva
Accelerating discovery of an efficacious Plasmodium viva
|
12-2025
|
A Phase 2 Study to Assess the Virologic Efficacy of REGN
A Phase 2 Study to Assess the Virologic Efficacy of REGN
|
08-2025
|
ID NOW¿ COVID-19
ID NOW¿ COVID-19
|
06-2025
|
Discovering the Essential Genome of Plasmodium Falciparum
Discovering the Essential Genome of Plasmodium Falciparum
|
03-2025
|
Protocol #6R88-COV-2040
Protocol #6R88-COV-2040
|
07-2024
|
A Phase 1b/2a, Randomized, Double-Blind, Placebo Control
A Phase 1b/2a, Randomized, Double-Blind, Placebo Control
|
06-2024
|
Protocol: AudibleHealth DX
Protocol: AudibleHealth DX
|
06-2024
|
Protocol: CoVPN 3006
Protocol: CoVPN 3006
|
03-2024
|
Immunological characterization of the P. vivax DBP
Immunological characterization of the P. vivax DBP
|
03-2024
|
A randomized, double-blind, placebo-controlled, multicen
A randomized, double-blind, placebo-controlled, multicen
|
12-2023
|
Unraveling mechanisms of stage conversion in malaria par
Unraveling mechanisms of stage conversion in malaria par
|
06-2023
|
A Phase 3, Randomized, Double-Blind, Placebo-Controlled
A Phase 3, Randomized, Double-Blind, Placebo-Controlled
|
06-2023
|
A Randomized, Double-Blind, Placebo Controlled, Trial to
A Randomized, Double-Blind, Placebo Controlled, Trial to
|
06-2023
|
R10933-10987-COV-2067
R10933-10987-COV-2067
|
06-2023
|
R10933-10987-COV-2066
R10933-10987-COV-2066
|
03-2023
|
Structural Vaccinology and Design of Novel Immunogens fo
Structural Vaccinology and Design of Novel Immunogens fo
|
08-2022
|
Discovering the Essential Genome of Plasmodium Falciparu
Discovering the Essential Genome of Plasmodium Falciparu
|
08-2022
|
Plasmodium ovale hypnozoite development and relapse: a c
Plasmodium ovale hypnozoite development and relapse: a c
|
05-2022
|
Therapeutics for Inpatients with COVID-19 or ITAC TO 10
Therapeutics for Inpatients with COVID-19 or ITAC TO 10
|
05-2022
|
Therapeutics for Inpatients with COVID-19 (TICO or ACT
Therapeutics for Inpatients with COVID-19 (TICO or ACT
|
04-2022
|
Evaluation of ivermectin as an antimalarial therapy agai
Evaluation of ivermectin as an antimalarial therapy agai
|
09-2021
|
Phase 2/3 Randomized, Placebo-Controlled, Double-Blind
Phase 2/3 Randomized, Placebo-Controlled, Double-Blind
|
06-2021
|
Toxoplasma Gondii cAMP-Dependent Kinase PKAc3 Regulation of Bradzoite Formation
Toxoplasma Gondii cAMP-Dependent Kinase PKAc3 Regulation of Bradzoite Formation
|
06-2021
|
Antimalarial Drugh Discovery Targeting Pre-Erythrocytic Stages of Plasmodium Falciparum
Antimalarial Drugh Discovery Targeting Pre-Erythrocytic Stages of Plasmodium Falciparum
|
02-2021
|
Exploiting cross-reactive, conserved epitopes in Plasmod
Exploiting cross-reactive, conserved epitopes in Plasmod
|
03-2020
|
Chemogenomic Profiling of Plasmodium Falciparum Drug Res
Chemogenomic Profiling of Plasmodium Falciparum Drug Res
|
12-2019
|
Determination of IC50 Values for Antibodies 667,2A10 and
Determination of IC50 Values for Antibodies 667,2A10 and
|
11-2019
|
Passively Regulated Cryogenic (PaRC) Vial System for Vaccine Distribution and Administration
Passively Regulated Cryogenic (PaRC) Vial System for Vaccine Distribution and Administration
|
09-2019
|
B Cell Epitope Mapping of Viral and Parasitic Antigens
B Cell Epitope Mapping of Viral and Parasitic Antigens
|
08-2019
|
B Cell Epitope Mapping of Viral and Parasitic Antigens
B Cell Epitope Mapping of Viral and Parasitic Antigens
|
06-2019
|
(FDOH, HB376): Physician Oversight, Medical Director & Research Coordination
(FDOH, HB376): Physician Oversight, Medical Director & Research Coordination
|
05-2019
|
Composition and Formation of the Cyst Wall
Composition and Formation of the Cyst Wall
|
08-2018
|
3D Microfluidic Human Liver Models for Malaria Drugs
3D Microfluidic Human Liver Models for Malaria Drugs
|
02-2018
|
Immunological Characterization of the P. Vivax DBP
Immunological Characterization of the P. Vivax DBP
|
03-2016
|
A Large-Scale Transponson Mutagenesis Screen of Pl
A Large-Scale Transponson Mutagenesis Screen of Pl
|
01-2015
|
A Forward Genetic Screen to Identify Determinants of Malaria Stage Conversion
A Forward Genetic Screen to Identify Determinants of Malaria Stage Conversion
|
07-2014
|
Draper Fellowship: Steven Maher
Draper Fellowship: Steven Maher
|
04-2014
|
Assays for Evaluating Pre-Erythrocytic Antigens Using a
Assays for Evaluating Pre-Erythrocytic Antigens Using a
|
11-2013
|
Genetic Screen for P. Vivax CQR
Genetic Screen for P. Vivax CQR
|
11-2013
|
Long-term Continuous Culture of Plamodium Vivax Blood Stages
Long-term Continuous Culture of Plamodium Vivax Blood Stages
|
08-2013
|
Draper Fellowship-Steven Maher
Draper Fellowship-Steven Maher
|
05-2013
|
Chemical Profiling of P. Falciparum Genetic Mutants to Optimize Drug Development
Chemical Profiling of P. Falciparum Genetic Mutants to Optimize Drug Development
|
12-2012
|
Functional Characterization of a Conserved Phosphase of Plasmodium Falciparum
Functional Characterization of a Conserved Phosphase of Plasmodium Falciparum
|
08-2012
|
Draper Fellowship-Steven Maher
Draper Fellowship-Steven Maher
|
08-2011
|
Fellowship for Steven Maher
Fellowship for Steven Maher
|
07-2011
|
Immunological Characterization of the P vivax DBP
Immunological Characterization of the P vivax DBP
|
04-2011
|
Evaluation of PvDBP-RII Immunogens for Immunogenicity and Protective Efficacy Toawrd the Development of an anti-DBP Vaccine against Plasmodium Vivax
Evaluation of PvDBP-RII Immunogens for Immunogenicity and Protective Efficacy Toawrd the Development of an anti-DBP Vaccine against Plasmodium Vivax
|
02-2011
|
PiggyBack Recombinant Plasmodium Falciparum Clones
PiggyBack Recombinant Plasmodium Falciparum Clones
|
12-2010
|
Regional Scientific Meeting of Global Health Programs
Regional Scientific Meeting of Global Health Programs
|
07-2010
|
Draper Laboratory Fellowship for Steven Maher
Draper Laboratory Fellowship for Steven Maher
|
02-2010
|
Molecular Analysis of Apical Organelles of Plasmodium
Molecular Analysis of Apical Organelles of Plasmodium
|
09-2009
|
Vivax Malaria Research III: 2009 and Beyond
Vivax Malaria Research III: 2009 and Beyond
|
05-2008
|
Developing a Transposon-based Tookit for Genetic Analysis of Malaria Parasites
Developing a Transposon-based Tookit for Genetic Analysis of Malaria Parasites
|